Cancer- Facts and Advice

True beam STX is installed in Max Hospital Patparganj. This machine is latest and unique in field of Radiation therapy which is loaded with artificial intelligence and able to deliver radiation therapy with stereotactic accuracy in 4D manner even in lesser than previous linac.  It will help me to treat moving, life threatening tumour like liver cancer, cholangioarcinoma as well as we able to do knife-less radio surgery in tumour where surgery clearance is difficult like AVM,  trigeminal neuralgia, and able to complete treatment in 1 day to within 1-2 weeks in case where time is crucial like stage IV so that we can start chemotherapy early. This is a magic linac  having ability to deliver SRS, FSRT,  SBRT,  SABR, Rapid arc,  IGRT,  IMRT etc.  In simple words "     चुन चुन कर कीटाणुअो का सफाई क...

Ewing sarcoma or other bone tumour mostly involve removal of limb and permanent disability. Even though, possibility of cure is low. Most of patient developed recurrence in lung or other organs which make incurable situations and people live with poor quality of disabled life. Then, one should not go for amputation when limb preserving treatment are oncologically safe and give same level of survival with good quality of life. Today, we saved a leg of a child from bone tumour by doing Extracorporeal Radiation therapy. Extracorporeal radiation therapy is one of safe, effective and cheap treatment option. It this process oncosurgeon remove diseased portion of bone and radiation oncologist sterilize bone by killing all cancer cell using ablative dose of radiation therapy to excised bone. This sterilized bone is now used as prosthesis / implant. Benefits of this implant / prosthesis is 1) free of cost, 2) part of his / her own body and 3) avoid need of postoperative radiation treatment...

A people drinking of hot boiling tea with alcohol (>15gm/day) have 1.5 times probability of developing oesophageal cancer. This is shown by a prospective study done over 456,155 normal persons (aged 30-79 years) in 2004-2008 in China (follow up period 9.2 years). 0.4% developed esophageal cancer. Reference -  Ann Intern Med 2018 Feb 6 early online , editorial can be found in  Ann Intern Med 2018 Feb 6 early online